Plasmid-induced cytotoxicity revealed by nanopore and nanostraw electroporation
Source abstract
Abstract
Transfecting clonal beta cells with large DNA plasmids holds significant promise for diabetes research. Existing transfection techniques like lipofection, viral transduction, and bulk electroporation often face limitations such as low efficiency and cytotoxicity. Nanoelectroporation, which utilizes nanopores or nanostraws and the application of mild electrical pulses, offers a gentle and safe alternative capable of delivering mRNAs and small to medium-sized plasmids. Nevertheless, efficiently transfecting cells with large plasmids via this approach remains challenging, and further improvements in efficiency are required. Here, we aimed to fill that need and optimized nanoelectroporation substrate properties to increase the transfection efficiency of GFP plasmids in clonal beta cells. We combined flow cytometry, fluorescence microscopy, and phase holographic microscopy to increase nanopore- and nanostraw transfection efficiency in terms of the delivered plasmid quantity. We found that the porosity needs to be high enough to allow the cells to interface enough nanopores, 200 nm nanopore diameter yielded higher transfection efficiency and lower cell death than 300 nm pores, and that the surface chemistry has a great effect on transfection efficiency due to differences in cell adhesion properties. Nanopores and nanostraws were compared and nanostraws were found to yield the highest immediate transfection efficiency. However, cells expressing GFP after 48 h were fewer than indicated immediately after transfection. We investigated the reasons behind this discrepancy in transfection efficiency assessed immediately- and 48 h after nanoelectroporation. Our results suggest that cells transfected with the most plasmids detach from the substrate within 48 h after transfection. This finding confirms that plasmids are cytotoxic, and it stresses the importance of achieving homogeneous transfection efficiencies among cells to be able to tune the amount of delivered plasmids appropriately.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Microbial Inactivation Methods · Microfluidic and Bio-sensing Technologies · Pancreatic function and diabetes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Division of Solid State Physics, Lund University, 221 00 Lund, Sweden
NanoLund, Lund University, 221 00 Lund, Sweden
Epigenetics and Diabetes Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Scania University Hospital, 214 28, Malmö, Sweden
Funding
Vetenskapsrådet · Stiftelsen för Strategisk Forskning · Crafoordska Stiftelsen · NanoLund, Lunds Universitet · H2020 European Research Council · Novo Nordisk Fonden
References (32)
Show source-provided references
1. Woods · Blood · 2003 · 101 · 128410.1182/blood-2002-07-2238 ↗
2. Kim · Anal. Bioanal. Chem. · 2010 · 397 · 317310.1007/s00216-010-3821-6 ↗
3. Zhong · Journal of Southern Medical University · 2008 · 28 · 1981
4. Chatterjee · Proc. Natl. Acad. Sci. U. S. A. · 2024 · 121 · e230780012010.1073/pnas.2307800120 ↗
5. Pei · Bioconjugate Chem. · 2019 · 30 · 27310.1021/acs.bioconjchem.8b00778 ↗
6. Batista Napotnik · Bioelectrochemistry · 2021 · 141 · 1078710.1016/j.bioelechem.2021.107871 ↗
7. Du · Drug Deliv. · 2018 · 25 · 151610.1080/10717544.2018.1480674 ↗
8. Adam Seger · Nanoscale · 2012 · 4 · 584310.1039/c2nr31700a ↗
9. Guillaume-Gentil · Small · 2013 · 9 · 190410.1002/smll.201202276 ↗
10. Nathamgari · Small · 2020 · 200261610.1002/smll.202002616 ↗
11. Chau · Nat. Commun. · 2024 · 15 · 440310.1038/s41467-024-48608-3 ↗
12. Sköld · Nanotechnology · 2010 · 21 · 15530110.1088/0957-4484/21/15/155301 ↗
13. Persson · Nano Res. · 2012 · 5 · 19010.1007/s12274-012-0199-0 ↗
14. VanDersarl · Nano Lett. · 2012 · 12 · 388110.1021/nl204051v ↗
15. Xie · ACS Nano · 2013 · 7 · 435110.1021/nn400874a ↗
16. Mukherjee · ACS Nano · 2018 · 12 · 1211810.1021/acsnano.8b05473 ↗
17. Cao · Proc. Natl. Acad. Sci. U. S. A. · 2019 · 116 · 789910.1073/pnas.1818553116 ↗
18. Lard · RSC Adv. · 2022 · 12 · 3029510.1039/D2RA05119B ↗
19. Cao · Sci. Adv. · 2018 · 4 · eaat813110.1126/sciadv.aat8131 ↗
20. Golshadi · Small · 2016 · 12 · 301410.1002/smll.201503878 ↗
21. Peer · ACS Nano · 2012 · 6 · 494010.1021/nn300443h ↗
22. Hebisch · Small · 2021 · 17 · 200642110.1002/smll.202006421 ↗
23. Ekstrand · RSC Adv. · 2024 · 14 · 2224410.1039/D4RA02791D ↗
24. Liu · Small · 2023 · 19 · 230308810.1002/smll.202303088 ↗
25. Schmiderer · Proc. Natl. Acad. Sci. U. S. A. · 2020 · 117 · 2126710.1073/pnas.2001367117 ↗
26. Wells-Holland · Nat Rev Mol Cell Biol · 2023 · 24 · 77110.1038/s41580-023-00627-6 ↗
27. Ekstrand · RSC Adv. · 2024 · 14 · 2224410.1039/D4RA02791D ↗
28. Haraguchi · Commun. Biol. · 2022 · 5 · 7810.1038/s42003-022-03021-8 ↗
29. Lesueur · Mol. Ther.–Nucleic Acids · 2016 · 5 · e29110.1038/mtna.2016.4 ↗
30. Shokouhi · Adv. Mater. · 2023 · 35 · 230412210.1002/adma.202304122 ↗
31. Yoh · Adv. Funct. Mater. · 2022 · 32 · 210482810.1002/adfm.202104828 ↗
32. Maurizi · Adv. Sci. · 2022 · 9 · e220325710.1002/advs.202203257 ↗